NSEShareholders meeting30 Jun 2026 · 30 Jun 2026, 07:32 pm

Shareholders meeting

Dr. Reddy's Laboratories Limited · DRREDDY

✦ AI SummaryMgmt Change

Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of 42nd Annual General Meeting to be held on July 23, 2026, to consider and pass various resolutions including re-appointment of a director, appointment of statutory auditors, and declaration of final dividend.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of 42nd Annual General Meeting to be held on July 23, 2026

Attachments (1)

📄

DRREDDY_30062026193148_AGM_Notice_sigend.pdf

pdf

Download →
View document text
Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com June 30, 2026 National Stock Exchange of India Ltd. (Scrip Code: DRREDDY) BSE Limited (Scrip Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY) Dear Sir/ Madam, Sub: Notice of 42nd Annual General Meeting Pursuant to the provisions of Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a copy of Notice convening the 42nd Annual General Meeting (“AGM”) of the Company, scheduled to be held on Thursday, July 23, 2026 at 11:00 A.M. IST through Video Conferencing/ Other Audio-Visual Means. The Notice of AGM is also available on the Company’s website and can be accessed at the following link: Notice of 42nd Annual General Meeting Please also refer below AGM related information: Time and date of AGM 11:00 a.m. IST, Thursday, July 23, 2026 Cut-off date Thursday, July 16, 2026 E-voting start time and date 9.00 a.m. IST, Sunday, July 19, 2026 E-voting end time and date 5.00 p.m. IST, Wednesday, July 22, 2026 E-voting website of NSDL https://www.evoting.nsdl.com/ Helpline number for VC +91-22-4886 7000 and +91-22-2499 7000 participation This is for your information and records. Thanking you. Yours faithfully, For Dr. Reddy’s Laboratories Limited K Randhir Singh Company Secretary, Compliance Officer and Head-CSR NOTICE OF 42ND ANNUAL GENERAL MEETING Regd. Office: 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500 034 CIN: L85195TG1984PLC004507, Tel: 91 40 4900 2900, Fax: 91 40 4900 2999 Email: shares@drreddys.com, Website: www.drreddys.com Notice is hereby given that the 42nd Annual General Meeting 3. To re-appoint Mr. K Satish Reddy (DIN: 00129701), as (“AGM”) of the members of Dr. Reddy’s Laboratories a Director, who retires by rotation and being eligible, Limited (“Company”) will be held on Thursday, July 23, has offered himself for re-appointment. 2026, at 11.00 a.m. (“IST”) through Video Conferencing To consider and, if thought fit, to pass, the following (“VC”)/ Other Audio-Visual Means (“OAVM”), to transact the resolution as an Ordinary Resolution: following businesses: “RESOLVED THAT pursuant to the applicable ORDINARY BUSINESS: provision(s) of the applicable law(s) (including any 1. To receive, consider and adopt the Audited Financial amendments thereto or re-enactment thereof for the Statements (Standalone and Consolidated) of the time being in force), in accordance with the Articles of Company for the financial year ended March 31, Association of the Company and upon recommendation 2026, together with the Reports of the Board of of the Nomination, Governance and Compensation Directors and Auditors thereon. Committee and the Board of Directors, Mr. K Satish To consider and, if thought fit, to pass, the following Reddy (DIN: 00129701), Director, who retires by resolution as an Ordinary Resolution: rotation and being eligible, has offered himself for re-appointment, be and is hereby re-appointed as a “RESOLVED THAT the audited standalone financial Director of the Company, liable to retire by rotation.” statements of the Company for the financial year ended March 31, 2026 together with the reports of the Board 4. To appoint M/s. Deloitte Haskins & Sells, LLP, of Directors and Auditors thereon, as circulated to the Chartered Accountants as Statutory Auditors for members, be and are hereby approved and adopted. a period of five consecutive years and fix their remuneration. RESOLVED FURTHER THAT the audited consolidated To consider and, if thought fit, to pass, the following financial statements of the Company for the financial resolution as an Ordinary Resolution: year ended March 31, 2026 together with the report of the Auditors thereon, as circulated to the members, be “RESOLVED THAT pursuant to the provisions of and are hereby approved and adopted.” Sections 139, 142 and other applicable provisions, if any, of the Companies Act, 2013 read with the Companies 2. To declare a final dividend of ` 8/- per equity share (Audit and Auditors) Rules, 2014, (including any statutory of the face value of ` 1/- each, for the financial year modification(s) or re-enactment thereof, for the time ended March 31, 2026. being in force) and based on the recommendations To consider and, if thought fit, to pass, the following of the Audit Committee and the Board of Directors, resolution as an Ordinary Resolution: M/s. Deloitte Haskins & Sells, LLP, Chartered Accountants (Firm Registration No.117366W/W-100018), “RESOLVED THAT approval be and is hereby accorded be and is hereby appointed as statutory auditors of for declaration and payment of final dividend of ₹ 8 the Company, in place of retiring auditors M/s. S. R. (Rupee Eight) per equity share of the face value of ₹ Batliboi & Associates LLP, Chartered Accountants (Firm 1 (Rupee One) each fully paid up, of the Company, as Registration No. 101049W/E300004), to hold office for recommended by the Board of Directors of the Company the period of five consecutive years commencing from for the financial year ended March 31, 2026." the conclusion of this 42nd Annual General Meeting until the conclusion of the 47th Annual General Meeting, at RESOLVED FURTHER THAT the Board of Directors such remuneration and reimbursement of out of pocket of the Company be and is hereby authorised to do and expenses based on the recommendation of the Audit perform all such acts, deeds, matters and things, as may Committee, as may be determined by the Board of be considered necessary, desirable or expedient to give Directors of the Company. effect to this resolution.” RESOLVED FURTHER THAT the Board of Directors of 6. To appoint Mr. Srikanth Velamakanni (DIN: 01722758) as an independent director of the Company. the Company or any duly constituted Committee of the Board, be and is hereby authorized to do all such acts, To consider, and if thought fit, to pass, the following deeds, matters and things as may be necessary, proper resolution as a Special Resolution: or expedient to give effect to this resolution.” “RESOLVED THAT pursuant to the provisions of SPECIAL BUSINESS Sections 149, 150, 152, 161, and other applicable provisions of the Companies Act, 2013 (“the Act”), 5. To re-appoint Dr. K P Krishnan (DIN: 01099097), as read with Schedule IV of the Act and the rules made an Independent Director for a second term of five consecutive years. thereunder, and the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) To consider and, if thought fit, to pass, the following Regulations, 2015 (“SEBI Listing Regulations”) (including resolution as a Special Resolution: any statutory modification(s) or re-enactment(s) thereof for the time being in force), and in accordance with the “RESOLVED THAT pursuant to the provisions of Articles of Association of the Company, and based on Sections 149, 152 and other applicable provisions of the recommendation of the Nomination, Governance and the Companies Act, 2013, (“Act”) read with Schedule Compensation Committee and the Board of Directors, IV of the Act and the Rules made thereunder, the Mr. Srikanth Velamakanni, (DIN: 01722758), who was applicable provisions of the SEBI (Listing Obligations appointed as an Additional Director in the category of an and Disclosure Requirements) Regulations, 2015 Independent Director with effect from July 1, 2026, who (“SEBI Listing Regulations”) (including any statutory meets the criteria of independence as prescribed under modification(s) or re-enactment(s) thereof for the time Section 149(6) of the Act and Regulation 16(1)(b) of the being in force), and in accordance with the Articles SEBI Listing Regulations, and in respect of whom the of Association of the Company, and based on the Company has received a notice in writin [Showing first 8,000 characters — download PDF for full document]